Sonata vs. Quviviq
See how Sonata and Quviviq compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Sonata is a short-acting sedative-hypnotic approved only for short-term insomnia, while Quviviq is a newer orexin blocker with no defined treatment-duration limit on its label.
Both carry warnings for complex sleep behaviors and are Schedule IV controlled substances, but Sonata is available as a much less expensive generic.
Sonata's very short half-life makes it useful for falling back asleep in the middle of the night, while Quviviq targets both sleep onset and sleep maintenance.
Sonata vs. Quviviq Drug Summary
Sonata
Sonata (zaleplon) is a nonbenzodiazepine sedative-hypnotic that treats short-term insomnia in adults. It comes as an oral capsule taken once nightly at bedtime, or in the middle of the night if at least four hours of sleep time remain. Its very short half-life helps limit next-day grogginess when dosed correctly.
Quviviq
Quviviq (daridorexant) is a dual orexin receptor antagonist that treats insomnia involving trouble falling asleep, staying asleep, or both. It is taken as a single oral tablet once nightly, close to bedtime, with several hours planned before waking. As a newer class of sleep medication, it works by blocking wake-promoting orexin signals rather than sedating the brain broadly.
Sonata vs. Quviviq Side Effects
Sonata
Quviviq
Sonata vs. Quviviq Dosage
Sonata
Quviviq
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 20 mg once nightly | If needed |
| Dose changes | 2 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg once nightly | At the start |
| Maximum dose | 50 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Sonata
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg once nightly | At the start |
| Maximum dose | 20 mg once nightly | If needed |
| Dose changes | 2 increases | As tolerated |
Quviviq
| STAGE | DOSE | WHEN |
| Starting dose | 25 mg once nightly | At the start |
| Maximum dose | 50 mg once nightly | If needed |
| Dose changes | 1 increase | As tolerated |
Sonata vs. Quviviq Indications
Sonata
Sonata is FDA-approved only for the short-term treatment of insomnia in adults, not for ongoing nightly use. It is not approved for anyone under 18. Doctors often prescribe it for people who need occasional help falling asleep or who wake in the night and need to fall back asleep quickly.
Short-term insomnia in adults only
Can be dosed mid-night if 4+ hours sleep remain
Not approved for chronic nightly use
Not approved for patients under 18
Quviviq
Quviviq is FDA-approved for insomnia in adults who have trouble falling asleep, staying asleep, or both. Unlike Sonata, its label does not restrict use to short-term treatment. It is not approved for narcolepsy and is contraindicated in people with that condition.
Insomnia with sleep-onset or maintenance issues
No short-term use restriction on the label
Not approved for narcolepsy
Contraindicated in narcolepsy patients
Sonata vs. Quviviq Pros and Cons
Sonata
Sonata's ultra-short half-life and non-CYP metabolism give it a distinct niche among hypnotics: fast onset, quick clearance, and few drug interactions. It's only approved for short-term use, and long-term nightly reliance falls outside its label. Generic pricing makes it one of the most affordable prescription sleep aids available.
Pros
Very short half-life may limit next-day grogginess
Can be taken mid-night if 4+ hours sleep remain
Metabolized without CYP enzymes, fewer interactions
Roughly $25 to $115 per month as a generic
Cons
Only approved for short-term insomnia treatment
Contains FD&C Yellow No. 5, a possible allergen
Needs lower dose in elderly or hepatic impaired
Quviviq
Quviviq offers a newer mechanism, blocking orexin signals instead of broadly sedating the brain, and its label does not limit use to short-term treatment. It requires no dose adjustment for kidney problems, though liver dosing needs care. Its list price is substantially higher than generic zaleplon.
Pros
No short-term use restriction on the label
No dose adjustment needed for kidney problems
No signs of physical dependence in trials
Newer orexin-blocking mechanism, an alternative option
Cons
Contraindicated in people with narcolepsy
Risk of worsening depression or suicidal thoughts
Roughly $520 to $685 per month, no generic yet
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.